381 related articles for article (PubMed ID: 31666085)
1. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants.
Tsubota M; Fukuda R; Hayashi Y; Miyazaki T; Ueda S; Yamashita R; Koike N; Sekiguchi F; Wake H; Wakatsuki S; Ujiie Y; Araki T; Nishibori M; Kawabata A
J Neuroinflammation; 2019 Oct; 16(1):199. PubMed ID: 31666085
[TBL] [Abstract][Full Text] [Related]
2. Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in Mice.
Tsujita R; Tsubota M; Hayashi Y; Saeki H; Sekiguchi F; Kawabata A
J Neuroimmune Pharmacol; 2018 Jun; 13(2):179-188. PubMed ID: 29196860
[TBL] [Abstract][Full Text] [Related]
3. Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats.
Nishida T; Tsubota M; Kawaishi Y; Yamanishi H; Kamitani N; Sekiguchi F; Ishikura H; Liu K; Nishibori M; Kawabata A
Toxicology; 2016 Jul; 365():48-58. PubMed ID: 27474498
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk.
Sekiguchi F; Domoto R; Nakashima K; Yamasoba D; Yamanishi H; Tsubota M; Wake H; Nishibori M; Kawabata A
Neuropharmacology; 2018 Oct; 141():201-213. PubMed ID: 30179591
[TBL] [Abstract][Full Text] [Related]
5. Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice.
Tsubota M; Miyazaki T; Ikeda Y; Hayashi Y; Aokiba Y; Tomita S; Sekiguchi F; Wang D; Nishibori M; Kawabata A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685531
[TBL] [Abstract][Full Text] [Related]
6. Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy.
Sekiguchi F; Kawabata A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396481
[TBL] [Abstract][Full Text] [Related]
7. Human soluble thrombomodulin-induced blockade of peripheral HMGB1-dependent allodynia in mice requires both the lectin-like and EGF-like domains.
Hayashi Y; Tsujita R; Tsubota M; Saeki H; Sekiguchi F; Honda G; Kawabata A
Biochem Biophys Res Commun; 2018 Jan; 495(1):634-638. PubMed ID: 29146186
[TBL] [Abstract][Full Text] [Related]
8. High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy.
Gu H; Wang C; Li J; Yang Y; Sun W; Jiang C; Li Y; Ni M; Liu WT; Cheng Z; Hu L
Int J Cancer; 2020 May; 146(10):2810-2821. PubMed ID: 31465111
[TBL] [Abstract][Full Text] [Related]
9. Role of high-mobility group box 1 and its modulation by thrombomodulin/thrombin axis in neuropathic and inflammatory pain.
Tsujita R; Tsubota M; Sekiguchi F; Kawabata A
Br J Pharmacol; 2021 Feb; 178(4):798-812. PubMed ID: 32374414
[TBL] [Abstract][Full Text] [Related]
10. [HMGB1 as a target for prevention of chemotherapy-induced peripheral neuropathy].
Kawabata A; Tsubota M; Sekiguchi F; Tsujita R
Nihon Yakurigaku Zasshi; 2019; 154(5):236-240. PubMed ID: 31735750
[TBL] [Abstract][Full Text] [Related]
11. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.
Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A
Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186
[TBL] [Abstract][Full Text] [Related]
12. Role of neuron-derived ATP in paclitaxel-induced HMGB1 release from macrophages and peripheral neuropathy.
Domoto R; Sekiguchi F; Kamaguchi R; Iemura M; Yamanishi H; Tsubota M; Wang D; Nishibori M; Kawabata A
J Pharmacol Sci; 2022 Jan; 148(1):156-161. PubMed ID: 34924121
[TBL] [Abstract][Full Text] [Related]
13. Development of hepatic impairment aggravates chemotherapy-induced peripheral neuropathy following oxaliplatin treatment: Evidence from clinical and preclinical studies.
Miyamoto T; Domoto R; Sekiguchi F; Kamaguchi R; Nishimura R; Matsuno M; Tsubota M; Fujitani M; Hatanaka S; Koizumi Y; Wang D; Nishibori M; Kawabata A
J Pharmacol Sci; 2022 Mar; 148(3):315-325. PubMed ID: 35177211
[TBL] [Abstract][Full Text] [Related]
14. Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis.
Tanaka J; Yamaguchi K; Ishikura H; Tsubota M; Sekiguchi F; Seki Y; Tsujiuchi T; Murai A; Umemura T; Kawabata A
Neuropharmacology; 2014 Apr; 79():112-8. PubMed ID: 24262631
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats.
Tanaka J; Seki Y; Ishikura H; Tsubota M; Sekiguchi F; Yamaguchi K; Murai A; Umemura T; Kawabata A
Br J Pharmacol; 2013 Nov; 170(6):1233-41. PubMed ID: 24004409
[TBL] [Abstract][Full Text] [Related]
16. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
[TBL] [Abstract][Full Text] [Related]
17. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
[TBL] [Abstract][Full Text] [Related]
18. Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy.
Yang X; Jia R; Hu F; Fan W; Lin T; Zhang X; Xu C; Ruan S; Jiang C; Li Y; Pan C; Yang Y; Hu L; Chen Q; Liu WT
Cell Commun Signal; 2023 May; 21(1):99. PubMed ID: 37143083
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes.
Ito T; Kawahara K; Okamoto K; Yamada S; Yasuda M; Imaizumi H; Nawa Y; Meng X; Shrestha B; Hashiguchi T; Maruyama I
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1825-30. PubMed ID: 18599803
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis.
Irie Y; Tsubota M; Ishikura H; Sekiguchi F; Terada Y; Tsujiuchi T; Liu K; Nishibori M; Kawabata A
J Neuroimmune Pharmacol; 2017 Dec; 12(4):693-707. PubMed ID: 28755135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
